KWMG
IBB icon

King Wealth Management Group’s iShares Biotechnology ETF IBB Stock Holding History

King Wealth Management Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$524K Buy
3,102
+1
+0% +$171 0.07% 101
2025
Q4 		$523K Sell
3,101
-15
-0.5% -$2.44K 0.06% 100
2025
Q3 		$450K Buy
3,116
+1
+0% +$136 0.06% 105
2025
Q2 		$394K Buy
3,115
+75
+2% +$9.21K 0.05% 110
2025
Q1 		$389K Sell
3,040
-10
-0.3% -$1.36K 0.06% 105
2024
Q4 		$403K Sell
3,050
-1
-0% -$141 0.06% 102
2024
Q3 		$444K Sell
3,051
-53
-2% -$7.67K 0.07% 94
2024
Q2 		$426K Sell
3,104
-105
-3% -$14K 0.07% 93
2024
Q1 		$440K Sell
3,209
-17
-0.5% -$2.32K 0.08% 90
2023
Q4 		$438K Sell
3,226
-62,419
-95% -$7.62M 0.08% 87
2023
Q3 		$8.03M Sell
65,645
-9,689
-13% -$1.23M 1.69% 17
2023
Q2 		$9.56M Buy
75,334
+144
+0.2% +$18.7K 1.93% 14
2023
Q1 		$9.71M Buy
75,190
+95
+0.1% +$12.4K 2.15% 12
2022
Q4 		$9.86M Sell
75,095
-33
-0% -$4.26K 2.36% 12
2022
Q3 		$8.79M Sell
75,128
-539
-0.7% -$66.9K 2.23% 12
2022
Q2 		$8.9M Sell
75,667
-2,146
-3% -$255K 2.13% 13
2022
Q1 		$10.1M Buy
77,813
+1,438
+2% +$187K 1.99% 14
2021
Q4 		$11.7M Buy
76,375
+1,259
+2% +$195K 2.16% 15
2021
Q3 		$12.1M Buy
75,116
+531
+0.7% +$89.4K 2.49% 12
2021
Q2 		$12.2M Buy
74,585
+231
+0.3% +$35.6K 2.5% 12
2021
Q1 		$11.2M Buy
74,354
+320
+0.4% +$50.8K 2.51% 11
2020
Q4 		$11.2M Sell
74,034
-154
-0.2% -$22K 2.63% 9
2020
Q3 		$10M Sell
74,188
-233
-0.3% -$31.6K 2.61% 10
2020
Q2 		$10.2M Buy
74,421
+67,722
+1,011% +$8.63M 2.99% 9
2020
Q1 		$722K Sell
6,699
-60
-0.9% -$6.91K 0.31% 50
2019
Q4 		$814K Buy
6,759
+394
+6% +$44K 0.22% 54
2019
Q3 		$633K Sell
6,365
-3
-0% -$314 0.18% 58
2019
Q2 		$695K Sell
6,368
-616
-9% -$65.5K 0.21% 56
2019
Q1 		$780K Sell
6,984
-376
-5% -$41.2K 0.24% 54
2018
Q4 		$710K Buy
7,360
+1
+0% +$106 0.26% 52
2018
Q3 		$898K Sell
7,359
-104
-1% -$12.2K 0.28% 48
2018
Q2 		$819K Hold
7,463
– – 0.28% 48
2018
Q1 		$797K Hold
7,463
– – 0.28% 49
2017
Q4 		$797K Buy
7,463
+2
+0% +$214 0.28% 50
2017
Q3 		$830K Hold
7,461
– – 0.31% 50
2017
Q2 		$771K Sell
7,461
-375
-5% -$36.9K 0.31% 54
2017
Q1 		$766K Buy
7,836
+108
+1% +$10.3K 0.32% 53
2016
Q4 		$684K Sell
7,728
-765
-9% -$69.6K 0.31% 51
2016
Q3 		$820K Buy
+8,493
New +$808K 0.41% 46
2016
Q1 		– Sell
-57,576
Closed -$6.49M – 107
2015
Q4 		$6.49M Sell
57,576
-327
-0.6% -$35.5K 3.58% 6
2015
Q3 		$5.86M Sell
57,903
-1,218
-2% -$146K 3.6% 7
2015
Q2 		$7.27M Buy
59,121
+108
+0.2% +$12.9K 3.98% 5
2015
Q1 		$6.76M Buy
59,013
+38,271
+185% +$4.22M 3.9% 6
2014
Q4 		$2.1M Buy
20,742
+17,742
+591% +$1.72M 1.11% 24
2014
Q3 		$273K Buy
+3,000
New +$263K 0.17% 81
2014
Q1 		– Sell
-26,151
Closed -$1.98M – 100
2013
Q4 		$1.98M Buy
26,151
+1,695
+7% +$120K 1.13% 26
2013
Q3 		$1.71M Buy
+24,456
New +$1.6M 1.11% 25

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

King Wealth Management Group's IBB Position: Q1 2026 in Review

King Wealth Management Group increased its iShares Biotechnology ETF (IBB) stake by 0.03% in Q1 2026, buying an estimated $171 and bringing the position to 3,102 shares worth $524K. The position accounts for 0.07% of the portfolio, ranked #101.

King Wealth Management Group first reported a position in IBB in Q3 2013 and has held it in 47 quarters since. The position peaked at $12.2M in Q2 2021. 918 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • King Wealth Management Group held 3,102 shares of iShares Biotechnology ETF worth $524K as of Q1 2026.
  • King Wealth Management Group bought 1 iShares Biotechnology ETF share in Q1 2026, an estimated $171.
  • iShares Biotechnology ETF made up 0.07% of King Wealth Management Group's portfolio in Q1 2026, its #101 holding.
  • King Wealth Management Group first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 47 quarters since.
  • King Wealth Management Group's iShares Biotechnology ETF position peaked at $12.2M in Q2 2021.
  • 918 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on King Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.